Renu Anand Ileller

Title: Renu Anand Ileller: Innovator in Aggrecanase Research

Introduction

Renu Anand Ileller is a prominent inventor based in Stanford, CA (US). She has made significant contributions to the field of biomedical research, particularly in the study of aggrecanase and its implications in various diseases. Her work has the potential to impact therapeutic approaches for conditions such as rheumatoid arthritis and osteoarthritis.

Latest Patents

Renu Anand Ileller holds a patent for "Human aggrecanase and nucleic acid compositions encoding the same." This patent encompasses human aggrecanase and related polypeptides, as well as nucleic acid compositions that encode these proteins. The applications of her inventions are vast, including research, diagnostics, and therapeutic agent screening. Additionally, her patent outlines methods for inhibiting aggrecanase activity in hosts and treating disease conditions associated with this enzyme.

Career Highlights

Renu Anand Ileller is associated with Syntex (U.S.A.) Inc., where she has been instrumental in advancing research in her field. Her innovative work has led to a deeper understanding of aggrecanase and its role in various diseases, paving the way for new treatment strategies.

Collaborations

Throughout her career, Renu has collaborated with notable colleagues, including Harold Edgar VanWart and John David Allard. These collaborations have further enriched her research and contributed to the advancement of knowledge in the field.

Conclusion

Renu Anand Ileller is a trailblazer in aggrecanase research, with a patent that holds promise for therapeutic advancements. Her contributions to the field are invaluable, and her work continues to inspire future innovations in biomedical research.